The Patent Finder

Prolx Pharmaceuticals Corp.

Also on record
Records under this name other than patents Prolx Pharmaceuticals Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Prolx Pharmaceuticals Corp.

PatentTitleStatus Expires Confidence
US 7,446,124Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic Agents
Formerly held
Lapsed on the fee record
Ended Nov 4, 2020 · High confidence
Lapsed on the fee recordEnded Nov 4, 2020High confidence
US 7,858,657Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic Agents
Formerly held
Lapsed on the fee record
Ended Dec 28, 2018 · High confidence
Lapsed on the fee recordEnded Dec 28, 2018High confidence
US 7,081,475Wortmannin Analogs and Methods of Using Same
Lapsed on the fee record
Ended Jul 25, 2018 · High confidence
Lapsed on the fee recordEnded Jul 25, 2018High confidence
US 6,372,772Inhibitors of redox signaling and methods of using same
Lapsed on the fee record
Ended Apr 16, 2014 · From the USPTO record
Lapsed on the fee recordEnded Apr 16, 2014From the USPTO record
US 7,629,128Methods of identifying respondents to hypoxia inducible factor 1-α inhibitors
Lapsed on the fee record
Ended Dec 8, 2013 · From the USPTO record
Lapsed on the fee recordEnded Dec 8, 2013From the USPTO record
US 7,399,785N-Oxides and Derivatives of Melphalan for Treating Diseased States Associated with Hypoxia Inducible Factor
Lapsed on the fee record
Ended Jul 15, 2012 · Low confidence
Lapsed on the fee recordEnded Jul 15, 2012Low confidence
US 6,552,060Asymmetric disulfides and methods of using same
Lapsed on the fee record
Ended Apr 22, 2011 · From the USPTO record
Lapsed on the fee recordEnded Apr 22, 2011From the USPTO record
US 5,602,278N-oxides and derivatives of chlorambucil for treating hypoxic tumor cells
Term ended
Term ended no later than Feb 11, 2017 · Low confidence
Term endedTerm ended no later than Feb 11, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited